Literature DB >> 1985940

Adipsin gene expression in 3T3-F442A adipocytes is posttranscriptionally down-regulated by retinoic acid.

J Antras1, F Lasnier, J Pairault.   

Abstract

Retinoic acid (RA) has been shown to inhibit the differentiation of 3T3 adipogenic cell lines. In this report, the steady-state levels of several adipose-specific mRNAs were studied in mature adipocytes treated with RA. Northern blot analysis showed that, following a 24-h exposure of 3T3-F442A adipocytic cultures to RA (10 microM), there was a 4-5-fold decrease of adipsin mRNA level. In contrast, actin, adipocyte P2, lipoprotein lipase, and glycerophosphate dehydrogenase mRNA levels were unchanged during the same interval. The rate of adipsin and actin gene transcription, assessed by nuclear run-on assays, remained unchanged in adipocytes exposed to RA. The half-life (t1/2) of adipsin mRNA, determined by pulse-chase with [3H] uridine, was greatly shortened in RA-treated adipocytes (t1/2 approximately 7.3 h) as compared with untreated cells (t1/2 approximately 37.6 h). Conversely, actin mRNA stability was not altered by the drug. These results suggest that RA can specifically down-regulate adipsin expression in adipocytes at a posttranscriptional level without inducing the reversal of adipocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985940

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Id3 prevents differentiation of preadipose cells.

Authors:  M Moldes; F Lasnier; B Fève; J Pairault; P Djian
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

2.  Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes.

Authors:  C Jacques; G Béréziat; L Humbert; J L Olivier; M T Corvol; J Masliah; F Berenbaum
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 3.  Control of adipocyte differentiation.

Authors:  C M Smas; H S Sul
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

4.  A pleiotropic element in the medium-chain acyl coenzyme A dehydrogenase gene promoter mediates transcriptional regulation by multiple nuclear receptor transcription factors and defines novel receptor-DNA binding motifs.

Authors:  M E Carter; T Gulick; D D Moore; D P Kelly
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

5.  Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes.

Authors:  T Scantlebury; A D Sniderman; K Cianflone
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

6.  Transcriptional down-regulation by insulin of the beta 3-adrenergic receptor expression in 3T3-F442A adipocytes: a mechanism for repressing the cAMP signaling pathway.

Authors:  B Fève; K Elhadri; A Quignard-Boulangé; J Pairault
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Retinoic acid receptor gamma 2 gene expression is up-regulated by retinoic acid in 3T3-L1 preadipocytes.

Authors:  Y Kamei; T Kawada; R Kazuki; E Sugimoto
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

8.  Overexpression of hormone-sensitive lipase prevents triglyceride accumulation in adipocytes.

Authors:  C Sztalryd; M C Komaromy; F B Kraemer
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Expression of the phosphoenolpyruvate carboxykinase gene in 3T3-F442A adipose cells: effects of retinoic acid and differentiation.

Authors:  J Antras-Ferry; S Franckhauser; D Robin; P Robin; D K Granner; C Forest
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

10.  Adrenocorticotrophic-hormone-dependent regulation of a mu-class glutathione transferase in mouse adrenocortical cells.

Authors:  L Mankowitz; L Staffas; M Bakke; J Lund
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.